SCHEMBL3769866

SCHEMBL3769866

Cc1ccc(N2C(=O)C=CC2=O)c(Br)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 12/20 0.55
HSP90AA1 P07900 4/20 0.47
CCR6 P51684 3/20 0.44
TLR9 Q9NR96 2/20 0.43
G6PD P11413 2/20 0.42
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
FAAH O00519 2/20 0.39
ACHE P22303 1/20 0.39
NPSR1 Q6W5P4 3/20 0.39
ALDH1A1 P00352 2/20 0.39
PKM P14618 2/20 0.39
HPGD P15428 2/20 0.39
HTT P42858 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MAPT P10636 1/20 0.39
NLRP1 Q9C000 1/20 0.39
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29510662 1.00 MGLL (0.55) MGLLHSP90AA1CCR6TLR9G6PD
SCHEMBL9067561 0.82 TLR9 (0.54) MGLLHSP90AA1CCR6TLR9G6PD
SCHEMBL29485049 0.80 MGLL (0.59) MGLLHSP90AA1CCR6TLR9G6PD
SCHEMBL5075633 0.80 MGLL (0.59) MGLLHSP90AA1TLR9G6PDFAAH
SCHEMBL717739 0.80 MGLL (0.59) MGLLHSP90AA1CCR6TLR9G6PD
SCHEMBL10587190 0.78 MGLL (0.57) MGLLHSP90AA1TLR9G6PDFAAH
SCHEMBL17867050 0.78 MGLL (0.54) MGLLHSP90AA1CCR6TLR9G6PD
SCHEMBL23388366 0.77 MGLL (0.55) MGLLHSP90AA1CCR6TLR9G6PD
SCHEMBL9838829 0.77 MGLL (0.55) MGLLHSP90AA1TLR9G6PDFAAH
SCHEMBL29485051 0.77 MGLL (0.55) MGLLHSP90AA1CCR6TLR9G6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114432301-B Covalent inhibitor derivative and application thereof in treatment of viral infection 北京大学 2024-05-31 CN disclosed
CN-114432301-A Covalent inhibitor derivative and application thereof in treating virus infection 北京大学 2022-05-06 CN disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE FADS2, ACOT7, FADS1 MGLL 316/4885HSP90AA1 4216/4885CCR6 2281/4885
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE FADS2, ACOT7, FADS1 MGLL 316/4885HSP90AA1 4216/4885CCR6 2281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.